ArticleAnnals of medicine2022

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.

Yuriko Nishiyama-Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.